Novartis to acquire Avidity Biosciences, an innovator in RNA therapeutics for $11 Billion
On Oct. 26, 2025, Novartis announced that it has entered into an agreement to acquire Avidity Biosciences, a…
Lilly to Acquire Adverum Biotechnologies for $12.47 per Share
On Oct. 24, 2025, Eli Lilly and Adverum Biotechnologies announced a definitive agreement for Lilly to acquire Adverum,…
Alkermes Announces Agreement to Acquire Avadel Pharmaceuticals for $2.1 billion
On Oct. 22, 2025, Alkermes and Avadel Pharmaceuticals announced the companies have entered into a definitive agreement under…
South Carolina Department of Public Health Confirms Measles Outbreak
On Oct. 22, 2025, the South Carolina Department of Public Health (SCDPH) announced it is actively responding to…
Pigs developed to be resistant to deadly virus
On Oct. 22, 2025, a Roslin Institute led team announced they have developed pigs that are resistant to…
Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…
Glaukos Announces FDA Approval of Epioxa™
On Oct. 20, 2025, Glaukos announced today the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD…
The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients
On Oct. 20, 2025, The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, announced it…
ACG to invest $200 million in U.S. hard-shell capsule manufacturing
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
Setback for Roche in Natco Pharma case as India Supreme Court allows generic drug sales
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
Boston Scientific Announces Agreement to Acquire Nalu Medical for $533 million
On Oct. 17, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Nalu Medical,…
FDA approves Novo Nordisk’s oral semaglutide for cardiovascular risk reduction in adults with type 2 diabetes
On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…
Diagnostics | Disease | FDA | Medicine | Pharmaceutical | Therapeutics
FDA unveils drugs to receive expedited review in support of ‘national priorities’
On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…
Broad Clinical Labs sets new GUINNESS WORLD RECORDS™ title for fastest DNA sequencing technique
On Oct. 15, 2025, Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, announced…
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
On Oct. 15, 2025, Danish drugmaker Novo Nordisk and Omeros announced they have signed a licensing deal worth…
Researchers Announce a phone book-sized surgical kit designed for the world’s most extreme environments
On Oct. 14, 2025, researchers Texas A&M University School of Engineering Medicine (EnMed) announced development of a portable…
WHO warns of widespread resistance to common antibiotics worldwide
On Oct. 13, 2025, the World Health Organization (WHO) reported that one in six laboratory-confirmed bacterial infections causing…
Bristol Myers Squibb Acquires Cell Therapy Portfolio with Acquisition of Orbital Therapeutics for $1.5 billion in cash
On Oct. 10, 2025, Bristol Myers Squibb (BMS) and Orbital Therapeutics announced a definitive agreement under which BMS…
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast) tablets as first new treatment option for adults with IPF in over a decade
On Oct. 9, 2025, Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug…
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
On Oct. 9, 2025, Celltrion announced announced that the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), biosimilar…
Biotechnology | Clinical Research | Infectious Disease | Medical Device | Therapeutics | Vaccine | WHO
WHO launches the Global Clinical Trials Forum
On Oct. 7, 2025, the World Health Organization (WHO) launched the Global Clinical Trials Forum (GCTF), a global,…
Bath scientists design peptide ‘switch’ that keeps Parkinson’s protein in its healthy form
On Oct. 6, 2025, Researchers at the University of Bath, in collaboration with the Universities of Oxford and…
the 2025 Nobel Prize in Physiology or Medicine awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”
On Oct. 6, 2026, The Nobel Assembly has awarded the 2025 Nobel Prize in Physiology or Medicine to Mary E….
FDA Announces New ANDA Prioritization Pilot to Support U.S. Generic Drug Manufacturing and Testing
On Oct. 3, 2025, the U.S. Food and Drug Administration (FDA) announced a new pilot prioritization program for…
South Carolina Department of Public Health Confirms Measles Outbreak
On Oct. 2, 2025, the South Carolina Department of Public Health )DPH) has confirms a measles outbreak in…
FDA approved Evita Solution’s generic version of the abortion drug, mifepristone
On Oct. 2, 2025, the U.S. Food and Drug Administration (FDA) approved Evita Solution’s generic version of the…
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
On Sept. 30, 2025, Pfizer announced an agreement with the Trump Administration that will ensure U.S. patients pay…
Solid dose vaccine protects pigs against virus
On Sept. 30, 2025, a team of researchers involving Roslin Institute scientists tested a solid dose of a…
Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US
On Sept. 26, 2025, Sanofi US announced a broad expansion of its Insulins Valyou Savings Program by offering…